DE60032781D1 - Nahrungsmittelzusatz zur zunahme der fettarmen körpermasse und kraft - Google Patents

Nahrungsmittelzusatz zur zunahme der fettarmen körpermasse und kraft

Info

Publication number: DE60032781D1
Authority: DE; Germany
Prior art keywords: food supplement; increasing; force; body mass; fatty body
Prior art date: 1999-10-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60032781T

Other languages

English (en)

Inventor

Paul T Gardiner

E Woodgate

S Gilbert

W Thoburn

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Muscletech Research and Development Inc

Original Assignee

Muscletech Research and Development Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-18

Filing date

2000-10-18

Publication date

2007-02-15

2000-01-13 Priority claimed from US09/482,688 external-priority patent/US6784209B1/en

2000-10-18 Application filed by Muscletech Research and Development Inc filed Critical Muscletech Research and Development Inc

2007-02-15 Application granted granted Critical

2007-02-15 Publication of DE60032781D1 publication Critical patent/DE60032781D1/de

2020-10-19 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

235000015872 dietary supplement Nutrition 0.000 title abstract 5
MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 abstract 2
150000001413 amino acids Chemical class 0.000 abstract 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
210000003205 muscle Anatomy 0.000 abstract 2
239000000126 substance Substances 0.000 abstract 2
102000004877 Insulin Human genes 0.000 abstract 1
108090001061 Insulin Proteins 0.000 abstract 1
230000037213 diet Effects 0.000 abstract 1
235000005911 diet Nutrition 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
229940125396 insulin Drugs 0.000 abstract 1
230000003278 mimic effect Effects 0.000 abstract 1
230000001502 supplementing effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
- A23C9/1512—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins containing isolated milk or whey proteins, caseinates or cheese; Enrichment of milk products with milk proteins in isolated or concentrated form, e.g. ultrafiltration retentate
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dispersion Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Endocrinology (AREA)
Obesity (AREA)
Hematology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)

DE60032781T 1999-10-18 2000-10-18 Nahrungsmittelzusatz zur zunahme der fettarmen körpermasse und kraft Expired - Lifetime DE60032781D1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US42043999A	1999-10-18	1999-10-18
US09/482,688 US6784209B1 (en)	1999-10-18	2000-01-13	Food supplement for increasing lean mass and strength
PCT/CA2000/001207 WO2001028356A2 (en)	1999-10-18	2000-10-18	Food supplement for increasing lean mass and strength

Publications (1)

Publication Number	Publication Date
DE60032781D1 true DE60032781D1 (de)	2007-02-15

Family

ID=27024851

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60032781T Expired - Lifetime DE60032781D1 (de)	1999-10-18	2000-10-18	Nahrungsmittelzusatz zur zunahme der fettarmen körpermasse und kraft

Country Status (12)

Country	Link
US (3)	US20040175442A1 (de)
EP (1)	EP1221865B1 (de)
JP (1)	JP2003511094A (de)
AT (1)	ATE349909T1 (de)
AU (1)	AU784752B2 (de)
CA (1)	CA2388733C (de)
CZ (1)	CZ20021346A3 (de)
DE (1)	DE60032781D1 (de)
MX (1)	MXPA02003861A (de)
NZ (1)	NZ518685A (de)
RU (1)	RU2002111408A (de)
WO (1)	WO2001028356A2 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020006907A1 (en) *	2000-02-01	2002-01-17	Paul Gardiner	Alpha lipoic acid based food supplement for increasing lean muscle mass and strength
GB2377639B (en) *	2000-04-19	2004-10-13	Humanetics Corp	A combination of pinitol and creatine to enhance uptake and retention of creatine
US7521481B2 (en)	2003-02-27	2009-04-21	Mclaurin Joanne	Methods of preventing, treating and diagnosing disorders of protein aggregation
JP2005027524A (ja) *	2003-07-08	2005-02-03	Ajinomoto Co Inc	経口アミノ酸組成物
US20050215640A1 (en)	2004-03-26	2005-09-29	Baxter Jeffrey H	HMB compositions and uses thereof
JP4849792B2 (ja) *	2004-09-14	2012-01-11	オリザ油化株式会社	美容用組成物
CA2588423A1 (en) *	2004-11-17	2006-05-26	Joanne Mclaurin	Compositions comprising scyllo-inositol derivatives and methods to treat disorders of protein aggregation
JP2006213684A (ja) *	2005-02-07	2006-08-17	Hokko Chem Ind Co Ltd	インスリン抵抗性改善に用いられる組成物及び健康用食品
CA2626005A1 (en) *	2005-10-13	2007-10-25	Waratah Pharmaceuticals Inc.	Inositol derivatives and their uses in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence
WO2007056176A2 (en) *	2005-11-03	2007-05-18	Southwest Immunology, Inc.	Compositions for preventing and reducing delayed onset muscle soreness
US8778992B2 (en) *	2005-12-19	2014-07-15	Abbott Laboratories	Method of using beta-hydroxy-beta-methylbutyrate to treat allergies and asthma
CN103054837A (zh) *	2006-03-09	2013-04-24	瓦拉塔药品公司	用于治疗蛋白积聚病症的环己烷多元醇制剂
US20070248696A1 (en) *	2006-04-25	2007-10-25	Mind Sports Nutrition Inc.	Composition and method for enhancing neuromuscular facilitation and cognitive functions
US20110028719A1 (en) *	2006-05-19	2011-02-03	Jacek Slon-Usakiewicz	Screening methods for amyloid beta modulators
WO2008025116A1 (en) *	2006-08-31	2008-03-06	New Nitro Formulations Ltd.	Composition and method for enhancing or promoting the activity of insulin, enhancing skeletal muscle growth, reducing skeletal muscle loss, and increasing the energy supply to skeletal muscle
US20100173960A1 (en) *	2006-09-21	2010-07-08	Antonio Cruz	The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative Diseases
EP2091566A4 (de) *	2006-11-24	2011-07-06	Waratah Pharmaceuticals Inc	Kombinationstherapien gegen alzheimer-krankheit und ähnliche erkrankungen
HRP20130768T1 (en) *	2007-04-12	2013-10-25	Waratah Pharmaceuticals, Inc.	Use of cyclohexanehexol derivatives in the treatment of ocular diseases
US20100144891A1 (en) *	2007-04-12	2010-06-10	Mclaurin Joanne	Use of cyclohexanehexol derivatives in the treatment of amyotrophic lateral sclerosis
CA2683546A1 (en) *	2007-04-12	2008-10-23	Joanne Mclaurin	Use of cyclohexanehexol derivatives in the treatment of .alpha.-synucleinopathies
US20110105626A1 (en) *	2007-04-12	2011-05-05	Mclaurin Joanne	Use of cyclohexanehexol derivatives for the treatment of polyglutamine diseases
CZ307483B6 (cs) *	2007-10-08	2018-10-10	BlaĹľek Glass s.r.o.	Pilník pro leštění nebo pilování materiálů, zejména na nehty a kůži
AU2009228250B2 (en) *	2008-03-26	2015-03-19	Glanbia Nutritionals (Ireland) Ltd.	Leucine-rich peptide compositions and methods for isolation
CA2740124A1 (en) *	2008-10-09	2010-04-15	Waratah Pharmaceuticals Inc.	Use of scyllo-inositols for the treatment of macular degeneration-related disorders
JP2010105946A (ja) *	2008-10-29	2010-05-13	Nof Corp	筋タンパク質増強剤及びこれを含む医薬品または食品
WO2010102214A2 (en)	2009-03-05	2010-09-10	University Of South Florida	Method and composition for modulating canonical wnt pathway using folate and inositol
TWI519242B (zh) *	2010-01-29	2016-02-01	亞培公司	包含鈣ｈｍｂ及可溶性蛋白質的營養乳劑
US9693577B2 (en)	2010-01-29	2017-07-04	Abbott Laboratories	Method of preparing a nutritional powder comprising spray dried HMB
JP5892947B2 (ja) *	2010-01-29	2016-03-23	アボット・ラボラトリーズＡｂｂｏｔｔＬａｂｏｒａｔｏｒｉｅｓ	噴霧乾燥ｈｍｂを含む栄養粉末
TWI580363B (zh)	2010-01-29	2017-05-01	亞培公司	包含鈣ｈｍｂ的營養乳劑
WO2011094548A1 (en)	2010-01-29	2011-08-04	Abbott Laboratories	Aseptically packaged nutritional liquids comprising hmb
TWI526161B (zh)	2010-06-10	2016-03-21	亞培公司	包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
EP2397125A1 (de) *	2010-06-15	2011-12-21	Histocell, S.L.	Antioxidationszusammensetzung
US8999424B2 (en)	2010-10-26	2015-04-07	Advanced Bio Development, Inc.	Performance enhancing composition and method of delivering nutrients
US9522161B2 (en)	2010-10-26	2016-12-20	Advanced Bio Development, Inc.	Performance enhancing composition and method of delivering nutrients
DK2658404T3 (da)	2010-12-29	2016-02-08	Abbott Lab	Ernæringsprodukter indbefattende et nyt fedtstofsystem indbefattende monoglycerider
ITFI20110252A1 (it)	2011-11-22	2013-05-23	Lo Li Pharma Srl	Composizione farmaceutica comprendente myo-inositolo e d-chiro-inositolo.
EP2745707A1 (de) *	2012-12-20	2014-06-25	Promo Pharma S.p.A.	Neutrazeutische Verbindung
GB201223365D0 (en) *	2012-12-24	2013-02-06	Provexis Natural Products Ltd	Compositions
US20170348417A1 (en)	2013-04-11	2017-12-07	Richard Louis Price	Treatment of attention deficit disorders and associated symptoms
US20150126572A1 (en) *	2013-04-11	2015-05-07	Richard Louis Price	Inositol-containing comestible units and methods of treating autistic spectrum disorder using the same
US10098848B2 (en)	2013-04-11	2018-10-16	Richard Louis Price	Inositol-containing comestible units and methods of treatment using the same
US10076541B2 (en) *	2013-12-05	2018-09-18	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Composition useful as a dietary supplement
EP2949223A1 (de)	2014-05-30	2015-12-02	University of Limerick	Nahrungsergänzungszusammensetzung zur Verbesserung des Massenstatus von fettfreiem Muskelgewebe bei erwachsenen Menschen
CA2969744A1 (en)	2014-12-05	2016-06-09	Can Technologies, Inc.	Animal feed supplement and method
WO2017044601A1 (en)	2015-09-11	2017-03-16	Abbott Laboratories	Powdered nutritional product containing branched-chain amino acids and a sugar alcohol
WO2017218004A1 (en) *	2016-06-17	2017-12-21	Michael Hudnall	Medical food for patients with chronic liver disease
EP3629772B1 (de) *	2017-05-31	2025-08-13	Kyowa Hakko Bio Co., Ltd.	Verwendung von citrullin und glutathion zur erhöhung der muskelmasse
CN111032052B (zh)	2017-06-23	2023-05-12	Can科技公司	改善肉品质的方法
BR102017018191A2 (pt)	2017-08-24	2019-03-26	Can Technologies, Inc.	Método para reduzir a incidência de miopatias peitorais em aves de corte, ração para reduzir a incidência de miopatias peitorais em aves de corte, ração para aves de corte e uso de um aditivo
US12016353B2 (en)	2017-11-08	2024-06-25	The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center)	Compositions and methods for aquaculturing
JP7296611B2 (ja) *	2018-08-03	2023-06-23	ビーエイチエヌ株式会社	一酸化窒素産生促進剤
TW202019863A (zh) *	2018-08-22	2020-06-01	瑞士商雀巢製品股份有限公司	組成物及其用途
CN115484939A (zh) *	2019-09-24	2022-12-16	雀巢产品有限公司	鲨肌醇及其作为胰岛素敏化剂的用途
JP2021165235A (ja) *	2020-04-06	2021-10-14	株式会社ファンケル	アトロジン−１発現抑制剤

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6054321A (ja) *	1983-09-01	1985-03-28	Chiyoda Yakuhin Kk	粘度の安定なグルコマンナンとビタミンｃの健康食品用製剤
NL8403433A (nl) *	1984-11-09	1986-06-02	Holland Melkunie	Voedingssuppletiepreparaat op basis van melkbestanddelen.
JPS63109736A (ja) *	1986-10-28	1988-05-14	Kyodo Nyugyo Kk	乳清蛋白質を含有する新規な固型食品
JPS63310827A (ja) *	1987-06-15	1988-12-19	Sanwa Kagaku Kenkyusho Co Ltd	ニコチン酸誘導体を主剤とする徐放性製剤
US5143842A (en) *	1988-11-01	1992-09-01	The University Of Colorado Foundation, Inc.	Media for normal human muscle satellite cells
ATE193440T1 (de) *	1989-03-08	2000-06-15	Univ Virginia	Arzneimittel für insulinresistente diabetiker
DE4229166A1 (de)	1992-09-01	1994-03-03	Deutsches Krebsforsch	Mittel zur Aufrechterhaltung und/oder Steigerung der Muskelleistung und Körperzellmasse
US5945452A (en) *	1993-06-11	1999-08-31	The Board Of Trustees Of The Leland Stanford Junior University	Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
US5550166A (en) *	1995-03-17	1996-08-27	Ostlund; Richard E.	Pinitol and derivatives thereof for the treatment of metabolic disorders
GB9510037D0 (en)	1995-05-18	1995-07-12	Sandoz Nutrition Ltd	Improvements in or relating to organic compounds
WO1997043912A1 (en) *	1996-05-23	1997-11-27	Otsuka Pharmaceutical Co., Ltd.	Food composition for lowering body fat content and improving body composition and method therefor
US5891441A (en) *	1996-07-08	1999-04-06	Diaz; Jose A.	Chemical composition and method for more rapidly aiding the absorption, binding an elimination of undigested fat in the human body
US5817329A (en) *	1997-02-28	1998-10-06	Gardiner; Paul T.	Nutritional supplement for increased muscle size and strength for body builders
US6019999A (en) *	1997-12-03	2000-02-01	Miller; David F.	Process for making liposomal ion-exchange whey protein and products thereof
CN1201599A (zh) *	1998-06-17	1998-12-16	李平	一种安全减肥食品
US6117872A (en) *	1998-06-23	2000-09-12	The Board Of Trustees Of The Leland Stanford Junior University	Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity
WO2000003684A2 (en) *	1998-07-16	2000-01-27	Aaron Tabor	Soy formulations and their use for promoting health
US20020068365A1 (en) *	1998-07-28	2002-06-06	Eric H. Kuhrts	Controlled release nitric oxide producing agents
US20010041187A1 (en) *	1998-10-20	2001-11-15	Carl W Hastings	Performance-enhancing dietary supplement
US6051236A (en) *	1998-11-12	2000-04-18	Pacifichealth Laboratories, Inc.	Composition for optimizing muscle performance during exercise
US6784209B1 (en) *	1999-10-18	2004-08-31	Muscletech Research And Development Inc.	Food supplement for increasing lean mass and strength
US20020006907A1 (en) *	2000-02-01	2002-01-17	Paul Gardiner	Alpha lipoic acid based food supplement for increasing lean muscle mass and strength

2000
- 2000-10-18 AU AU78948/00A patent/AU784752B2/en not_active Expired
- 2000-10-18 CA CA2388733A patent/CA2388733C/en not_active Expired - Lifetime
- 2000-10-18 EP EP00969121A patent/EP1221865B1/de not_active Expired - Lifetime
- 2000-10-18 CZ CZ20021346A patent/CZ20021346A3/cs unknown
- 2000-10-18 WO PCT/CA2000/001207 patent/WO2001028356A2/en not_active Ceased
- 2000-10-18 JP JP2001530960A patent/JP2003511094A/ja active Pending
- 2000-10-18 DE DE60032781T patent/DE60032781D1/de not_active Expired - Lifetime
- 2000-10-18 MX MXPA02003861A patent/MXPA02003861A/es active IP Right Grant
- 2000-10-18 RU RU2002111408/13A patent/RU2002111408A/ru not_active Application Discontinuation
- 2000-10-18 NZ NZ518685A patent/NZ518685A/en unknown
- 2000-10-18 AT AT00969121T patent/ATE349909T1/de not_active IP Right Cessation
2004
- 2004-03-11 US US10/799,028 patent/US20040175442A1/en not_active Abandoned
- 2004-03-11 US US10/799,038 patent/US7795204B2/en not_active Expired - Lifetime
- 2004-06-22 US US10/874,526 patent/US20040234626A1/en not_active Abandoned

Also Published As

Publication number	Publication date
RU2002111408A (ru)	2004-05-20
MXPA02003861A (es)	2003-07-14
US7795204B2 (en)	2010-09-14
JP2003511094A (ja)	2003-03-25
US20040175443A1 (en)	2004-09-09
ATE349909T1 (de)	2007-01-15
AU7894800A (en)	2001-04-30
AU784752B2 (en)	2006-06-08
NZ518685A (en)	2004-04-30
EP1221865B1 (de)	2007-01-03
CA2388733A1 (en)	2001-04-26
WO2001028356A3 (en)	2001-11-01
US20040175442A1 (en)	2004-09-09
CZ20021346A3 (cs)	2003-06-18
CA2388733C (en)	2012-09-18
US20040234626A1 (en)	2004-11-25
EP1221865A2 (de)	2002-07-17
WO2001028356A2 (en)	2001-04-26

Publication	Publication Date	Title
DE60032781D1 (de)	2007-02-15	Nahrungsmittelzusatz zur zunahme der fettarmen körpermasse und kraft
HK1049431A1 (zh)	2003-05-16	用於增加肌肉塊和力量的食物補充方法
WO2001056402A3 (en)	2002-08-22	Alpha lipoic acid based food supplement to increase lean muscle mass and strength
DK1455603T3 (da)	2007-02-05	Stimulering af in vivo produktion af proteiner med en formulering, der omfatter leucin
WO2002100329A3 (en)	2003-08-21	Methods and compositions for helping the body resist the effects of the aging process
ES2173109T3 (es)	2002-10-16	Alimentos de unso medico destinados parael sostenimiento nutricional de recien nacidos/de bebes que padecen enfermedades metabolicas.
PL1898724T3 (pl)	2011-02-28	Preparat odżywczy dla niemowląt z hydrolizowanymi białkami
BR9711278A (pt)	1999-08-17	FÄrmula nutricional para pacientes com fenilcetonÚria
WO2004027064A3 (en)	2004-11-18	Ghrh analogues
WO2004028434A3 (en)	2004-10-14	Nocturnal muscle enhancing composition and method
CY1108138T1 (el)	2014-02-12	Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
IT1315252B1 (it)	2003-02-03	Compresse gastroresistenti ad uso alimentare o dietetico ottenutemediante grassi miscelati alla massa
WO2005123108A3 (en)	2006-05-04	Advanced vitamins and protein based nutritional supplements
TW200513197A (en)	2005-04-16	Amino acid supplementation for a healthy microbiota ecosystem
CA2502740A1 (en)	2004-05-06	Senior feline food
AU2003294856A8 (en)	2004-07-22	Use of von tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders
DE69826270D1 (de)	2004-10-21	Zinc und linolsäure enthaltendes nährungsmittel
CN101757038A (zh)	2010-06-30	一种蜂蜜花粉胶囊
AU5366699A (en)	2000-03-14	Food supplements comprising lipoic acid and creatine and methods for their use
EE200300220A (et)	2003-08-15	Bifidobacterium'i perekonna probiootiliste tüvedeskriinimise meetod
WO2001089315A3 (en)	2002-08-01	Method of enhancing growth, fluid consumption and feed conversion in birds
CN101757096A (zh)	2010-06-30	一种健脑口服液
WO2006134135A3 (en)	2007-04-12	Nutritional method for elderly people
FR2838645B1 (fr)	2004-05-28	Nouvelles compositions synergiques de vitamines, de mineraux et d'oligo-elements pour stimuler l'elimination des lipides intracellulaires
JPS62186762A (ja)	1987-08-15	健康維持調味料

Legal Events

Date	Code	Title	Description
2007-12-06	8332	No legal effect for de